Prostate cancer: High KI-67 does not predict hormone resistance
Objectives: To evaluateKi-67 expression in metastatic prostate tumors and correlate it with overall survival and progression-free survival data in patients submitted to central hormone blockade. Methods: Retrospective analysis of medical records and review of biological material of 45 patients with metastatic prostate cancer who were diagnosed and followed up at the São Paulo Medical School, Universidade Federal de São Paulo, São Paulo, Brazil, from 2000 to 2013.